Skip to main content
. 2022 Jan 29;107(5):1239–1246. doi: 10.1210/clinem/dgac046

Figure 2.

Figure 2.

Overall survival time by adrenocortical carcinoma stage. A total of 621 patients: stage I (23, 3.7%), stage II (203, 33%), stage III (198, 32.1%), and stage IV disease (192, 31.2%).